Search | Médecins Sans Frontières Access Campaign

2705 results found

Technical brief |

24 November 2023

Q&A: Access to cabotegravir long-acting (CAB-LA) for HIV pre-exposure prophylaxis (PrEP)

Q&A on access to HIV prevention drug CAB-LA

Tags HIV/AIDS HIV/AIDS cabotegravir ViiV

Between 2000-2021, the measles vaccine saved 56 million lives. In 2022, MSF provided 4 million measles vaccines in response to outbreaks.

Infographic

Vaccine infographics

Tags Tuberculosis tuberculosis

Technical brief |

15 November 2023

Access to TB Testing and Treatments: GeneXpert and Delamanid

The access barriers on lifesaving TB tools

Tags Tuberculosis drug-resistant TBtuberculosis GeneXpert CepheidOtsuka

Dr Samsuddin Khan performs physical exam of Deepak Sabhash Shegar, a person living with DR-TB, at MSF DR-TB clinic, Chembur, Mumbai, India, 2022

Press release |

15 November 2023

Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options

endTB clinical trial offers new shortened drug regimens to treat multidrug-resistant TB

Tags Tuberculosis drug-resistant TBtuberculosis UNITAID

Issue brief |

15 November 2023

Addressing Antimicrobial Resistance Within Global Processes to Improve Pandemic Preparedness and Response

Ongoing PPR processes offer a promising pathway to complement and help implement pre-existing commitments on AMR

Tags Pandemic preparednessAntimicrobial resistance

MSF Medical Doctor Ramya, conducting physical examination of female DRTB patient during her follow-up visit to endTB clinic.

Press release |

14 November 2023

MSF warns governments are failing to test, treat and prevent TB in children

Governments must immediately implement latest WHO guidelines to stop children dying from TB

Tags Tuberculosis drug-resistant TBtuberculosis GeneXpert World Health Organization

Improving access to insulin pens for people living with diabetes

Events |

14 November 2023

World Diabetes Day: How insulin pens improve the lives of people with diabetes

On World Diabetes Day, we showcase the benefits of insulin pens for people living with diabetes

Tags Diabetes Insulin

Photo credit: Carmen Yahchouchi

Blog |

14 November 2023

World Diabetes Day: how insulin pens can improve the lives of people living with diabetes

Diabetes is a chronic disease that demands lifelong management. It impacts all age groups — children, and young and older adults — and if not managed properly, there can be devastating consequences. Lack of access to insulin for people with type 1 diabetes is fatal.

Blog |

10 November 2023

DNDi: 20 years of delivering treatments for neglected patients

Video |

08 November 2023

Access to insulin pens in Lebanon

MSF has transitioned all patients with type 1 diabetes in our clinics in Lebanon from vials to insulin pens. Here are the stories from patients and staff about how the move has improved both medical outcomes and patients’ quality of ...

Tags Diabetes Diabetes Insulin

Video |

08 November 2023

Access to insulin pens - Moussa

Tags Diabetes Diabetes Insulin

Video |

08 November 2023

Access to insulin pens - Siwar

Tags Diabetes Diabetes Insulin

Video |

08 November 2023

Access to insulin pens - Ali

Tags Diabetes Insulin

GeneXpert test technology has revolutionised the diagnosis of TB, allowing detection of the TB bacterium, and its resistance to drugs, in only two hours.

Press release |

07 November 2023

MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease

Recent price reductions to WHO-recommended TB tests and treatment should enable more countries to make these vital medical tools available

Tags Tuberculosis drug-resistant TBtuberculosis GeneXpertbedaquiline World Health Organization

Letter |

01 November 2023

Letter: Civil society calls on UK Prime Minister to ensure UK-India free trade agreement does not threaten access to affordable medicines

Open letter to UK Prime Minister on UK-India free trade agreement and access to medicines

Tags Intellectual property and trade free trade agreement

Different medications a person living with HIV may take every day. Upper-left picture shows a first line treatment. Upper-right is a second-line treatment for patients who do not respond to first-line treatment. Bottom-left is a third-line treatment for patients who do not respond to first- and second-line treatments. Bottom-right is a dolutegravir pill, a new molecule that suppresses viral load much faster than others.

Press release |

04 October 2023

In step to expand people's access to HIV treatment, Colombia plans to overcome patent barriers and issue a compulsory license

Colombia plans to issue compulsory license on HIV drug dolutegravir, expanding access

Tags HIV/AIDSIntellectual property and trade

January 2020 protest in front of the New York Stock Exchange, demanding J&J make bedaquiline more accessible for all people with drug-resistant TB.

Press release |

30 September 2023

MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries

MSF welcomes Johnson & Johnson's intent not to enforce its patents on key TB drug bedaquiline, paving way for affordable generic versions

Tags Tuberculosis tuberculosis bedaquiline Johnson & Johnson

Vaishnavi, 7, who lives with drug-resistant TB, interacts with MSF nurse Prachi, as her mother Vishaka holds her. Mumbai, India, 2022.

Press release |

22 September 2023

Commitments made in today's UN TB Declaration to scale up TB testing and treatment, and improve TB care for children, require immediate, concrete action

Governments must now turn words on paper into practice and take the necessary steps to save more lives of people with TB

Tags Tuberculosis drug-resistant TBtuberculosis

Fact sheet |

22 September 2023

Tuberculosis: Challenges and Breakthroughs

Despite being curable, why is TB the world’s deadliest infectious disease? What tools do we have to beat the disease?

Tags Tuberculosis drug-resistant TBtuberculosis

Letter |

21 September 2023

Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis

The Public Health Center of the Ministry of Ukraine (PHC) sent this open letter to the US pharmaceutical corporation Johnson & Johnson (J&J) requesting urgent action to improve equitable access to the lifesaving TB drug bedaquiline in ...

Tags Intellectual property and trade tuberculosis bedaquiline Johnson & Johnson Ukraine

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

Q&A: Access to cabotegravir long-acting (CAB-LA) for HIV pre-exposure prophylaxis (PrEP)

Vaccine infographics

Access to TB Testing and Treatments: GeneXpert and Delamanid

Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options

Addressing Antimicrobial Resistance Within Global Processes to Improve Pandemic Preparedness and Response

MSF warns governments are failing to test, treat and prevent TB in children

World Diabetes Day: How insulin pens improve the lives of people with diabetes

World Diabetes Day: how insulin pens can improve the lives of people living with diabetes

DNDi: 20 years of delivering treatments for neglected patients

Access to insulin pens in Lebanon

Access to insulin pens - Moussa

Access to insulin pens - Siwar

Access to insulin pens - Ali

MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease

Letter: Civil society calls on UK Prime Minister to ensure UK-India free trade agreement does not threaten access to affordable medicines

In step to expand people's access to HIV treatment, Colombia plans to overcome patent barriers and issue a compulsory license

MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries

Commitments made in today's UN TB Declaration to scale up TB testing and treatment, and improve TB care for children, require immediate, concrete action

Tuberculosis: Challenges and Breakthroughs

Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis